Repertoire Launches To Turn Immune System Insights Into T-Cell Therapies, Vaccines

 
• By Mandy Jackson
  
T cell lymphocyte with receptors to kill cancer cell in cancer immunotherapy 3D render
Repertoire's first clinical trial is for an autologous T-cell therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip